Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341-Reference-Cited by-同舟云学术

Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

Published:2011-02-23 Issue:4 Volume:29 Page:247-252
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Fang Yong,Hu Yi,Wu Peng,Wang Beibei,Tian Yuan,Xia Xi,Zhang Qinghua,Chen Tong,Jiang Xuefeng,Ma Quanfu,Xu Gang,Wang Shixuan,Zhou Jianfeng,Ma Ding,Meng Li

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2010.496756

Reference31 articles.

1. The biology of ovarian cancer: new opportunities for translation

2. Anticancer activities of histone deacetylase inhibitors

3. Development of histone deacetylase inhibitors for cancer treatment

4. Histone deacetylase inhibitors: gathering pace

5. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer;Cell Death & Disease;2022-01-17

2. Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors;Molecular Oncology;2016-05-17

3. Proteasome and HDAC Inhibition Changes the Expression Levels of Bcl-2, Bcl-XL, Bim and Bik Proteins in Androgen-Independent PC-3 Cell Line;Gazi Medical Journal;2015-10-01

4. The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors;Endocrine-Related Cancer;2014-03-21

5. Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines;Genetics and Molecular Research;2014